ADC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Birrell, G
Right arrow Articles by Cheetham, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Birrell, G
Right arrow Articles by Cheetham, T
Archives of Disease in Childhood 2004;89:745-750
© 2004 BMJ Publishing Group & Royal College of Paediatrics and Child Health


REVIEW

Juvenile thyrotoxicosis; can we do better?

G Birrell, T Cheetham

Department of Paediatrics, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK

Correspondence to:
Correspondence to:
Dr T D Cheetham
Children’s Out Patient Department, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK; t.d.cheetham{at}ncl.ac.uk


ABSTRACT
Thyrotoxicosis remains a frustrating condition for the young person, family, and health professionals involved. The associated symptoms do not always suggest thyroid disease and patients can be unwell for many months before the diagnosis is made. The antithyroid drug regimen used to treat children and adolescents with thyrotoxicosis varies from one unit to another and yet the potentially life threatening side effects and remission rates post-treatment may be related to the regimen used. Most patients with thyrotoxicosis will need many years of drug therapy if the thyroid gland is not removed surgically or destroyed by radioiodine. Even "definitive" treatment will typically necessitate thyroxine replacement for life.


Abbreviations: PTU, propylthiouracil; RI, radioiodine; TBII, thyroid binding inhibiting immunoglobulin; TSH, thyrotropin

Keywords: Graves disease; thyrotoxicosis




This article has been cited by other articles:


Home page
Arch. Dis. Child.Home page
E. Posner
Practical algorithms in pediatric endocrinology, 2nd revised edition
Arch. Dis. Child., February 1, 2008; 93(2): 186 - 186.
[Full Text] [PDF]


Home page
JNMHome page
A. Iagaru and I. R. McDougall
Treatment of Thyrotoxicosis
J. Nucl. Med., March 1, 2007; 48(3): 379 - 389.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. C. Travis and M. G. Stabin
131I Ablation Treatment in Young Females After the Chernobyl Accident
J. Nucl. Med., October 1, 2006; 47(10): 1723 - 1727.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health